Related Experiment Video
Updated: Apr 1, 2026
08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.8K
MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma
Francine Tesser-Gamba1,2, Luana Joyce da Silva Lopes3, Antonio Sergio Petrilli4
1Department of Pediatrics, Genetics Laboratory, Pediatric Oncology Institute (IOP/GRAACC), Federal University of São Paulo, São Paulo-SP, Brazil.
Molecular Carcinogenesis
|October 14, 2015
Summary
Silencing the MAPK7 gene effectively suppresses osteosarcoma cell proliferation, migration, and invasion. This finding highlights MAPK7 as a potential therapeutic target for osteosarcoma treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Osteosarcomas (OS) are the most common primary malignant bone tumors.
- Effective biomarkers and therapeutic targets are crucial for improving patient outcomes in OS.
- Mitogen-activated protein kinase (MAPK) pathways are critical in cellular signaling and cancer development.
Purpose of the Study:
- To investigate the functional role of the MAPK7 gene in osteosarcoma (OS) cell lines.
- To evaluate MAPK7 as a potential therapeutic target for OS.
- To understand MAPK7's influence on OS cell behavior and gene expression.
Main Methods:
- Investigated MAPK7 gene function in OS cell lines through gene silencing.
- Assessed cell viability, proliferation, migration, and invasion.
- Analyzed the impact of MAPK7 modulation on transcription factors and key genes within the MAPK pathway.
Main Results:
- Silencing the MAPK7 gene significantly suppressed OS cell proliferation.
- MAPK7 gene silencing inhibited cell migration and invasion.
- MAPK7 acts as a key activator of transcription factors and modulates the expression of other critical genes in the MAPK pathway.
Conclusions:
- MAPK7 plays a significant role in the progression of osteosarcoma.
- Targeting MAPK7 demonstrates potential for novel therapeutic strategies in OS.
- MAPK7 is a promising prognostic marker and therapeutic target for osteosarcoma.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
5.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.1K
03:03mTOR Signaling and Cancer Progression
1.7K
1.7K
01:07MAPK Signaling Cascades
9.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K
01:22PI3K/mTOR/AKT Signaling Pathway
6.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.3K
02:23Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
01:19Interactions Between Signaling Pathways
7.9K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K